Senior insider sale
Chief Scientific Officer at VOYAGER THERAPEUTICS, INC. — senior position signals high conviction
$40.6K
11K shares
What this filing means
CARTER TODD ALFRED plans to sell 11K shares of VOYAGER THERAPEUTICS, INC. valued at approximately $40.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/24/2026ACC: 0001959173-26-001451
Officer· Chief Scientific Officer
Since Feb 2026
11K
Shares to sell
$40.6K
Approx. market value
4.17K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/20/2026
4.17KTotal acquired4.17K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/20/2026 | Restricted Stock Vesting Compensation | 4.17K | — |
| Total | 4.17K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
3.30K
Market value
$11.3K
2/18/2026
—Completed
Units to sell
3.52K
Market value
$13.6K
2/10/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.17K
Market value
$15.7K
2/24/2026
Total
Units
11K
Value
$40.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/18/2026 | 3.30K | $11.3K | — | Completed |
2/10/2026 | 3.52K | $13.6K | — | Completed |
| Planned — Approximate Date | ||||
2/24/2026 | 4.17K | $15.7K | NASDAQ | Planned |
| Total | 11K | $40.6K | ||